ArticleTrials2026

Prophylactic para-aortic irradiation vs pelvic radiotherapy in pelvic node-positive carcinoma cervix in the setting of concurrent chemoradiation: a phase II open-label multi centric randomized controlled trial (PRO-PARA).

PROPARA Trialist GroupPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.